360 High-Risk Vulnerability Immunization Tool V2.0 vs Redpalm Vulnerability Assessment / VMaaS: 2026 Comparison

360 High-Risk Vulnerability Immunization Tool V2.0

Startups and SMBs with Windows-heavy infrastructure and patching backlogs should run 360 High-Risk Vulnerability Immunization Tool V2.0 first; it immunizes against the specific CVEs that drive ransomware campaigns (MS17-010, CVE-2019-0708) without requiring immediate OS updates. The tool supports Windows 7 through current versions and deploys on-premises, meaning air-gapped networks can actually use it. Skip this if you're looking for NIST PR.PS coverage beyond platform hardening,this tool stops known exploits, not supply chain attacks or firmware-level threats.

Redpalm Vulnerability Assessment / VMaaS

Mid-market and SMB security teams without dedicated vulnerability management staff should pick Redpalm Vulnerability Assessment for its monthly consultant-led review cycle; you get both automated daily scanning and actual human interpretation of findings, not just a report dump. The service includes Cyber Essentials compliance tracking with 14-day critical patch remediation windows, which directly addresses ID.RA and DE.CM requirements under NIST CSF 2.0. Skip this if your organization already has mature internal VA processes or needs real-time alert routing; Redpalm's strength is guidance and compliance handholding, not speed or integration breadth.